Shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) Rise as it Adds Amy Yoder to its Board Of Directors

Agricultural technology company, Arcadia Biosciences, Inc. (NASDAQ:RKDA), has announced that Amy Yoder is joining its board of directors.

Arcadia Biosciences, Inc. (RKDA), an agricultural technology company that creates value for farmers while benefitting the environment and enhancing human health, announced today that Amy Yoder has joined its board of directors.

Yoder is president and CEO of Anuvia Plant Nutrients, a company that creates enhanced plant nutrition products from recycled organic waste sources. She is the former president and CEO of Arysta Life Science and has held a variety of senior sales, marketing and executive positions with companies throughout the agricultural and related industries, including Spectrum Brands, BioLab and United Agri Products. Yoder received a bachelor’s degree in agricultural technology and systems management from Michigan State University, with an emphasis in crop and soil science.

Yoder has served on boards of various agricultural associations and universities and was recognized as Atlanta’s “Business Woman to Watch” in 2007. She currently serves as a director for Compass Minerals International and Vive Crop Protection.

“Amy is an accomplished leader with an extensive network and broad industry experience across various agriculture sectors,” said George Gosbee, chair of the board of directors. “Her deep knowledge of the capital markets and public board governance expertise will be a valuable addition to the board.”

About Arcadia Biosciences, Inc.

Based in Davis, Calif., Arcadia Biosciences (RKDA) develops agricultural products that create added value for farmers while benefitting the environment and enhancing human health. Arcadia’s agronomic performance traits, including Nitrogen Use Efficiency, Water Use Efficiency, Salinity Tolerance, Heat Tolerance and Herbicide Tolerance, are all aimed at making agricultural production more economically efficient and environmentally sound. Arcadia’s nutrition traits and products are aimed at creating healthier ingredients and whole foods with lower production costs. For more information, visit www.arcadiabio.com.

Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: the company’s expectations of Amy Yoder’s potential contributions as a member of the company’s board of directors and the other risks set forth in the company’s filings with the Securities and Exchange Commission from time to time, including the risks set forth in the company’s annual report on Form 10-K for the year ended December 31, 2016 and other filings. These forward-looking statements speak only as of the date hereof, and Arcadia Biosciences, Inc. disclaims any obligation to update these forward-looking statements.

Original Source

Shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) are actively moving +3.776% thus far today on the news and have traded in the range of $0.386 – 0.440 during the session.  A number of research firms have recently weighed in on the stock, providing future price targets. The covering firms currently have a consensus one-year price target of $1.000 on the stock.  This is according to brokerage analysts polled by Thomson Reuters First Call.  This is the average number from the individual targets provided by the firms.  Analysts are projecting earnings per share of $-0.110 for the next fiscal quarter.  For the current year, analysts are predicting earnings of $-0.430 per share according to First Call.

In looking at where the stock is trading on a technical level, the stock is trading -15.113% away from its 50-day moving average of $0.489.  Based on the most recent available data, the equity is -83.400% off of its 52-week high of $2.500 and +38.333% away from its 52-week low which is $0.300.

Are Shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) Ready to Explode?  Sign up to our Newsletter to be the First to Know

Sign up to get our Free Penny Stock Picks Before the Street!

Today, the stock opened at $0.420 and the last bid at the time of writing stood at $0.415.  During the session thus far, the equity dipped down to $0.386 and touched $0.440 as the high point.  Arcadia Biosciences, Inc. (NASDAQ:RKDA) has a market cap of $17.71M and has seen an average daily volume of 142,005 over the past three months.

Sign Up to Receive Breaking Alerts on Stocks That Are Primed to Make a Run in the Bar Below.

Sign up to get our Free Penny Stock Picks Before the Street!

Disclaimer: The advice provided on this website is general advice only. It has been prepared without taking into account your objectives, financial situation or needs. Before acting on this advice you should consider the appropriateness of the advice, having regard to your own objectives, financial situation and needs.  Where quoted, past performance is not indicative of future performance.

Leave a Comment